Status:

COMPLETED

Investigate a Varnish to Protect From Erosive Toothwear

Lead Sponsor:

Colgate Palmolive

Conditions:

Tooth Erosion

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

This in-situ study will investigate on extracted teeth the protection of a re-formulated varnish containing fluoride in the same concentration as an existing approved varnish used to treat caries and ...

Eligibility Criteria

Inclusion

  • Males and females, between 18-70 years of age
  • Informed Consent Form signed and availability for the duration of the study
  • Good general health (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study.
  • Examples include heart problems, valve/hip replacements, etc);
  • Willingness to provide information related to their medical history
  • BEWE screen (Basic erosive wear examination) of score 2 or below (no evidence of severe tooth wear)
  • Normal salivary flow
  • Willingness to wear an intra-oral appliance all day as instructed except when eating and drinking.

Exclusion

  • Oral pathology, chronic disease, or a history of allergy to testing products;
  • Subject using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study;
  • Subject participating in any other clinical study;
  • Subject pregnant or breastfeeding;
  • Subject allergic to oral care products, personal care consumer products, or their ingredients;
  • Extended use of antibiotics or therapeutic mouthwash any time during the three months prior to entry into the study;
  • A medical history reporting that the subject has a current systemic or autoimmune disease, such as diabetes, lupus, etc.;
  • Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine);
  • Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone). Pocket depth equal or greater than 4 mm
  • Five or more decayed, untreated dental sites (cavities);
  • Current smokers and subjects with a history of alcohol or drug abuse;
  • Dental work prevents wearing of the appliance or a reported need to wear a night guard.

Key Trial Info

Start Date :

April 8 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 27 2022

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT06136754

Start Date

April 8 2022

End Date

July 27 2022

Last Update

November 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

King's College London

London, United Kingdom